What is Revvity's life sciences — total assets?

Revvity (RVTY) reported life sciences — total assets of $8.4B in Q4 2023.

What does life sciences — total assets mean?

The total value of resources owned or controlled by the Life Sciences segment.

How do you interpret life sciences — total assets?

An increase suggests growth in the segment's operational footprint or asset base, while a decrease may indicate divestitures or asset write-downs.

How does life sciences — total assets compare across companies?

Standard segment-level asset disclosure required for companies reporting under segment accounting standards.

Revvity RVTY Life Sciences — Total Assets

Discontinued — last reported Q4 '23

Similar metrics at other companies

DCILife Sciences Segment — Total Assets

$453M-12.5%

ALife Sciences and Diagnostics Markets — Total Assets

$6B—

TMOLife Sciences Solutions — Segment assets

$3.49B+15.6%

DHRLife Sciences — Identifiable assets

$22.87B—

STEHealthcare and Life Sciences — Total Assets

$5.37B+49.5%

ALife Sciences and Applied Markets — Total Assets

$3.14B-0.7%

Other financials

Income statement

See full

Revenue$711.1M+7.0%

Gross profit$387.7M+3.2%

Operating income$75.9M+5.1%

Net income$40.7M-3.6%

EPS (diluted)$0.36+2.9%

Balance sheet

See full

Cash & equivalents$861.5M-24.3%

Total debt$3.9B+17.8%

Total equity$7.2B-5.9%

Total assets$12.0B-2.9%

Cash flow

See full

Operating cash flow$115.2M-10.1%

CapEx$19.8M+23.7%

Free cash flow$95.5M-14.9%

Valuation

See full

Market cap$11.16B-22.9%

Enterprise value$14.24B-13.7%

P/E46.5×-4.0×

P/S3.8×-1.4×

Profitability

See full

Gross margin48.5%—

Operating margin12.4%-1.1pp

Net margin8.3%-2.1pp

FCF margin17%-1.9pp

Returns & leverage

See full

Return on equity3.2%-0.5pp

Debt / equity0.5×+0.1×

Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Revvity’s 10-K, filed February 27, 2024, on SEC EDGAR. View the filing →

Ask your AI about Revvity's life sciences — total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Revvity's life sciences — total assets?: Revvity (RVTY) reported life sciences — total assets of $8.4B in Q4 2023.
What does life sciences — total assets mean?: The total value of resources owned or controlled by the Life Sciences segment.
How do you interpret life sciences — total assets?: An increase suggests growth in the segment's operational footprint or asset base, while a decrease may indicate divestitures or asset write-downs.
How does life sciences — total assets compare across companies?: Standard segment-level asset disclosure required for companies reporting under segment accounting standards.